Beacon Investment Advisory Services Inc. Grows Stake in Kenvue Inc. (NYSE:KVUE)

Beacon Investment Advisory Services Inc. raised its position in Kenvue Inc. (NYSE:KVUE) by 2.7% during the 4th quarter, Holdings Channel reports. The firm owned 241,990 shares of the company’s stock after acquiring an additional 6,296 shares during the quarter. Beacon Investment Advisory Services Inc.’s holdings in Kenvue were worth $5,166,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. First PREMIER Bank grew its stake in Kenvue by 109.8% in the 4th quarter. First PREMIER Bank now owns 11,664 shares of the company’s stock valued at $249,000 after acquiring an additional 6,104 shares during the last quarter. GoalVest Advisory LLC lifted its holdings in shares of Kenvue by 35.4% in the fourth quarter. GoalVest Advisory LLC now owns 94,897 shares of the company’s stock valued at $2,026,000 after purchasing an additional 24,835 shares in the last quarter. Park Place Capital Corp grew its position in shares of Kenvue by 5.0% in the fourth quarter. Park Place Capital Corp now owns 11,930 shares of the company’s stock valued at $255,000 after purchasing an additional 572 shares during the last quarter. Dakota Wealth Management increased its stake in shares of Kenvue by 25.6% during the 4th quarter. Dakota Wealth Management now owns 14,454 shares of the company’s stock worth $309,000 after purchasing an additional 2,947 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its stake in shares of Kenvue by 151.0% during the 4th quarter. Nisa Investment Advisors LLC now owns 573,797 shares of the company’s stock worth $12,251,000 after purchasing an additional 345,199 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have commented on KVUE shares. UBS Group lowered their target price on Kenvue from $24.00 to $23.00 and set a “neutral” rating on the stock in a report on Thursday, January 16th. Barclays decreased their price objective on Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Piper Sandler upgraded Kenvue from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $21.00 to $26.00 in a research report on Monday, January 6th. JPMorgan Chase & Co. upped their target price on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a “buy” rating to a “hold” rating and lowered their price target for the stock from $25.00 to $24.00 in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $23.08.

Kenvue Trading Down 0.3 %

NYSE KVUE opened at $20.73 on Thursday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a one year low of $17.67 and a one year high of $24.46. The company’s 50 day moving average price is $22.31 and its 200 day moving average price is $21.75. The firm has a market capitalization of $39.75 billion, a price-to-earnings ratio of 37.70, a PEG ratio of 2.00 and a beta of 1.46.

Kenvue (NYSE:KVUE) last issued its earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.92 billion. During the same quarter last year, the firm posted $0.31 EPS. The business’s revenue for the quarter was down .4% compared to the same quarter last year. On average, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be given a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.95%. The ex-dividend date is Wednesday, February 12th. Kenvue’s payout ratio is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.